Bioequivalence study of two drug forms in healthy men
Part of Kidney & urinary clinical trials.
This trial tests whether two versions of a drug, AD-116A and AD-1161, are equally effective and safe in the body. Healthy adult male volunteers take the drug and have their blood levels compared.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult male.
- You must be at least 19 years old.
- Your weight must be 50 kg (110 lbs) or more.
- Your body mass index (BMI) must be between 18.0 and 30.0.
- You cannot have taken part in another drug study in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This trial compares two versions of a drug to see if they work the same in the body when taken with food. Healthy adult male volunteers are needed.
This study tests whether two formulations of a prostate medication (AJU-G721 and G721R) work the same way in your body. Researchers give both versions to healthy volunteers to make sure they're equally effective and safe.
This study tests whether two versions of the same medication (AJU-G721 and G721R)—used to treat hair loss and urinary symptoms—work the same way in the body. Researchers will measure how much medication gets absorbed and how long it stays in your system.
This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.